This educational program will aim to discuss cannabidiol use for medical disorders, specifically epilepsy. The content will compare cannabidiol from other cannabis-related products, illustrate the mechanisms of action of cannabidiol for epilepsy, and review current clinical data in this area, and discuss the importance of shared decision making in clinical practice, including education on the efficacy and safety profiles of cannabidiol to address misconceptions with patients and caregivers.

RELEASED DATE: October 17, 2024
EXPIRATION DATE: October 17, 2025

This educational program will discuss the burden of idiopathic hypersomnia (IH), assess mechanisms that address underlying pathology of the disease, and analyze available clinical data that look at the effect of treatment on sleep habits, quality of life, and cardiovascular risk. The program will also use guidelines and cases to describe best practices in patient counseling to ensure effective use of approved therapy for IH.

RELEASED DATE: October 18, 2024
EXPIRATION DATE: October 18, 2025

This educational activity is designed to help learners better understand the history of developmental and epileptic encephalopathies (DEEs), utilize genetic evaluation for patients with DEEs, and review best practices for managing the comprehensive burdens of DEEs.

RELEASED DATE: October 31, 2024
EXPIRATION DATE: October 31, 2025

In this enduring activity, we will provide learners with an overview of idiopathic hypersomnia, focusing on early identification and diagnosis, and both nonpharmacologic and pharmacologic treatment options. We will help improve clinicians’ ability to distinguish between IH and other sleep disorders, interpret the latest efficacy and safety data for approved and off-label treatments, and understand the increased cardiovascular risk linked to IH and other sleep disorders.

RELEASED DATE: November 04, 2024
EXPIRATION DATE: November 04, 2025